Review Article
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
Table 2
Selected studies of local treatment in oligometastatic NSCLC with mixed metastatic sites.
| Study | Year | N | Criteria | Treatment | Findings |
| Hanagiri et al. [21] (retrospective) |
2011 | 36 | Up to 5 metastastic sites, stage IV disease | Surgery or radiation | 5-year OS with distant metastasis 30.1%, pleural dissemination 25.1% |
Guerra et al. [22] (retrospective) | 2012 | 78 | Up to 5 synchronous metastatic sites, Definitive chemoRT (44 also underwent treatment to OM sites) | Surgery or radiation to OM sites | High radiation dose, performance status, lower intrathoracic tumor volume correlated with improved OS | Downey et al. [23] (prospective) | 2002 | 23 | Solitary synchronous lesions | MVP × 3, then surgery on all sites, then VP × 2 | MVP poorly tolerated, 2/23 patients disease free at 5 years |
|
|